NORTH CHICAGO, Ill. , Feb. 17, 2022 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.41 per share.  The cash dividend is payable May 16, 2022 to stockholders of record at the close of business on April 15, 2022 .

- Reports Full-Year Diluted EPS of $6.45 on a GAAP Basis, an Increase of 137.1 Percent; Adjusted Diluted EPS of $12.70, an Increase of 20.3 Percent - Delivers Full-Year Net Revenues of $56.197 Billion on a GAAP Basis, an Increase of 22.7 Percent; Adjusted Net Revenues Were $56.122 Billion -

NORTH CHICAGO, Ill. , Jan. 5, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its fourth-quarter and full-year 2021 financial results on Wednesday, February 2, 2022 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT .

NORTH CHICAGO, Ill. , Jan. 4, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 40 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 . Members of AbbVie's executive leadership team will present virtually at 2:45 p.m. CT , including Robert A.

NORTH CHICAGO, Ill. , Nov. 23, 2021 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the 4 th Annual Evercore ISI Virtual HealthCONx Conference on Thursday, December 2, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief

NORTH CHICAGO, Ill. , Nov. 23, 2021 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Piper Sandler 33 rd Annual Virtual Healthcare Conference on Wednesday, December 1, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief

NORTH CHICAGO, Ill. , Nov. 10, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wolfe Research Healthcare Conference on Wednesday, November 17, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial officer, and

- Reports Third-Quarter Diluted EPS of $1.78 on a GAAP Basis, an Increase of 38.0 Percent; Adjusted Diluted EPS of $3.33, an Increase of 17.7 Percent - Delivers Third-Quarter Net Revenues of $14.342 Billion, an Increase of 11.2 Percent on a GAAP Basis; Adjusted Net Revenues Increased 11.3 Percent

NORTH CHICAGO, Ill. , Oct. 5, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2021 financial results on Friday, October 29, 2021 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .

NORTH CHICAGO, Ill. , Sept. 10, 2021 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.30 per share.  The cash dividend is payable November 15, 2021 to stockholders of record at the close of business on October 15, 2021 .